Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$71.58 - $87.29 $451,097 - $550,101
6,302 New
6,302 $461,000
Q3 2023

Nov 15, 2023

BUY
$73.94 - $80.67 $266,405 - $290,654
3,603 New
3,603 $270,000
Q1 2023

May 12, 2023

BUY
$77.31 - $88.08 $210,205 - $239,489
2,719 New
2,719 $225,000
Q2 2022

Aug 09, 2022

SELL
$57.72 - $65.01 $431,052 - $485,494
-7,468 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$57.92 - $72.58 $432,546 - $542,027
7,468 New
7,468 $444,000
Q4 2021

Feb 14, 2022

SELL
$64.88 - $73.64 $223,316 - $253,468
-3,442 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $232,988 - $251,369
3,442 New
3,442 $240,000
Q2 2021

Aug 05, 2021

SELL
$63.47 - $69.35 $465,996 - $509,167
-7,342 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$60.0 - $68.46 $440,520 - $502,633
7,342 New
7,342 $475,000
Q4 2020

Feb 03, 2021

SELL
$56.65 - $64.55 $510,643 - $581,853
-9,014 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$62.1 - $78.08 $559,769 - $703,813
9,014 New
9,014 $570,000
Q1 2020

May 12, 2020

SELL
$62.63 - $80.22 $360,936 - $462,307
-5,763 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$61.62 - $67.78 $493,329 - $542,646
-8,006 Reduced 58.15%
5,763 $374,000
Q3 2019

Nov 12, 2019

SELL
$62.51 - $69.0 $288,046 - $317,952
-4,608 Reduced 25.07%
13,769 $873,000
Q2 2019

Aug 06, 2019

SELL
$61.87 - $69.38 $171,379 - $192,182
-2,770 Reduced 13.1%
18,377 $1.24 Million
Q1 2019

May 15, 2019

SELL
$62.53 - $70.05 $136,190 - $152,568
-2,178 Reduced 9.34%
21,147 $1.38 Million
Q4 2018

Feb 12, 2019

BUY
$60.54 - $79.0 $56,241 - $73,391
929 Added 4.15%
23,325 $1.46 Million
Q3 2018

Nov 13, 2018

SELL
$71.28 - $78.92 $1.44 Million - $1.6 Million
-20,216 Reduced 47.44%
22,396 $1.73 Million
Q2 2018

Aug 09, 2018

SELL
$64.88 - $75.68 $443,065 - $516,818
-6,829 Reduced 13.81%
42,612 $3.02 Million
Q1 2018

May 11, 2018

SELL
$72.84 - $88.8 $3.76 Million - $4.58 Million
-51,563 Reduced 51.05%
49,441 $3.73 Million
Q4 2017

Feb 14, 2018

BUY
$71.15 - $83.52 $6.81 Million - $8 Million
95,761 Added 1826.45%
101,004 $7.24 Million
Q3 2017

Nov 20, 2017

BUY
$72.11 - $85.47 $378,072 - $448,119
5,243
5,243 $425,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.